Graves Disease Latest Advances

The "Coca-Cola bottle sign" in Graves' ophthalmopathy.

Journal: Medicina

Published: April 10, 2026

Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: April 09, 2026

Clinical efficacy of endoscopic transnasal orbital decompression combined with optic nerve decompression for Graves ophthalmopathy: a retrospective study

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: April 09, 2026

Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning.

Journal: Endocrine journal

Published: April 08, 2026

Hypoxia-Induced Ferroptosis Resistance Drives Orbital Fibrosis in Thyroid Eye Disease.

Journal: Investigative ophthalmology & visual science

Published: April 08, 2026

Evaluation of ocular findings in patients with thyroid eye disease: Is medial rectus insertion involvement a clinical activity marker?

Journal: European journal of ophthalmology

Published: April 08, 2026

OptiDON-Guard: An Ensemble Model for Identification of Dysthyroid Optic Neuropathy Using Optical Coherence Tomography Angiography.

Journal: Translational vision science & technology

Published: April 08, 2026

CT-Free Quantitative Thyroid SPECT Based on Artificial Intelligence: A Prospective Multicenter Noninferiority Clinical Trial.

Journal: Thyroid : official journal of the American Thyroid Association

Published: April 07, 2026

Role of oncostatin M and its receptor in the inflammatory pathogenesis of Graves' orbitopathy.

Journal: Immunopharmacology and immunotoxicology

Published: April 06, 2026

Updates on Treatment in Thyroid Eye Disease for the Neurologist.

Journal: Neurologic clinics

Published: April 01, 2026

Bullous pemphigoid and Graves' disease developing during prolonged remission of pemphigus vulgaris.

Journal: European journal of dermatology : EJD

Published: March 23, 2026

Late-Onset and Recurrent Agranulocytosis During Low-Dose Methimazole Therapy in an Adolescent with Graves' Disease.

Journal: Journal of clinical research in pediatric endocrinology

Published: March 16, 2026

Graves Disease Latest Advances

Find the Latest Research About Graves Disease

The "Coca-Cola bottle sign" in Graves' ophthalmopathy.

The "Coca-Cola bottle sign" in Graves' ophthalmopathy.

Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort Study.

Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort Study.

Clinical efficacy of endoscopic transnasal orbital decompression combined with optic nerve decompression for Graves ophthalmopathy: a retrospective study

Clinical efficacy of endoscopic transnasal orbital decompression combined with optic nerve decompression for Graves ophthalmopathy: a retrospective study

Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning.

Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning.

Hypoxia-Induced Ferroptosis Resistance Drives Orbital Fibrosis in Thyroid Eye Disease.

Hypoxia-Induced Ferroptosis Resistance Drives Orbital Fibrosis in Thyroid Eye Disease.

Evaluation of ocular findings in patients with thyroid eye disease: Is medial rectus insertion involvement a clinical activity marker?

Evaluation of ocular findings in patients with thyroid eye disease: Is medial rectus insertion involvement a clinical activity marker?

OptiDON-Guard: An Ensemble Model for Identification of Dysthyroid Optic Neuropathy Using Optical Coherence Tomography Angiography.

OptiDON-Guard: An Ensemble Model for Identification of Dysthyroid Optic Neuropathy Using Optical Coherence Tomography Angiography.

CT-Free Quantitative Thyroid SPECT Based on Artificial Intelligence: A Prospective Multicenter Noninferiority Clinical Trial.

CT-Free Quantitative Thyroid SPECT Based on Artificial Intelligence: A Prospective Multicenter Noninferiority Clinical Trial.

Role of oncostatin M and its receptor in the inflammatory pathogenesis of Graves' orbitopathy.

Role of oncostatin M and its receptor in the inflammatory pathogenesis of Graves' orbitopathy.

Updates on Treatment in Thyroid Eye Disease for the Neurologist.

Updates on Treatment in Thyroid Eye Disease for the Neurologist.

Bullous pemphigoid and Graves' disease developing during prolonged remission of pemphigus vulgaris.

Bullous pemphigoid and Graves' disease developing during prolonged remission of pemphigus vulgaris.

Late-Onset and Recurrent Agranulocytosis During Low-Dose Methimazole Therapy in an Adolescent with Graves' Disease.

Late-Onset and Recurrent Agranulocytosis During Low-Dose Methimazole Therapy in an Adolescent with Graves' Disease.